Biohaven (BHVN) News Today $14.77 +0.81 (+5.80%) Closing price 03:59 PM EasternExtended Trading$14.80 +0.03 (+0.17%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHVN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 23, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. ...June 22, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 22, 2025 | prnewswire.comBiohaven Ltd. (NYSE:BHVN) Receives Consensus Rating of "Buy" from BrokeragesJune 20, 2025 | marketbeat.comBiohaven-aandeel raakt 52-weeks dieptepunt bij $ 14,32June 18, 2025 | nl.investing.comBiohaven Enters Oversold Territory (BHVN)June 18, 2025 | nasdaq.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 18, 2025 | globenewswire.comBiohaven (NYSE:BHVN) Sets New 1-Year Low on Analyst DowngradeJune 18, 2025 | marketbeat.comJPMorgan Chase & Co. Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock PriceJune 18, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Short Interest UpdateJune 17, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 15, 2025 | globenewswire.comBiohaven Insiders Added US$6.28m Of Stock To Their HoldingsJune 13, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 12, 2025 | prnewswire.comBiohaven (NYSE:BHVN) Shares Down 6.2% - Should You Sell?June 11, 2025 | marketbeat.comBexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug DevelopmentJune 10, 2025 | globenewswire.comCantor Fitzgerald Comments on Biohaven FY2026 EarningsJune 10, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 10, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 7, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 6, 2025 | globenewswire.comBiohaven Ltd. Highlights Strategic Focus in Investor PresentationJune 4, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 2, 2025 | globenewswire.comProtect Your Investment: Contact Levi & Korsinsky About the Biohaven Ltd. (BHVN) InvestigationJune 1, 2025 | markets.businessinsider.comMorgan Stanley Keeps Their Buy Rating on Biohaven Ltd. (BHVN)June 1, 2025 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. ...June 1, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 1, 2025 | prnewswire.comBiohaven Pharma Stock Price HistoryJune 1, 2025 | investing.comJim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy”June 1, 2025 | insidermonkey.comWellington Management Group LLP Acquires 390,888 Shares of Biohaven Ltd. (NYSE:BHVN)June 1, 2025 | marketbeat.comTwo Sigma Investments LP Reduces Stock Holdings in Biohaven Ltd. (NYSE:BHVN)June 1, 2025 | marketbeat.comH.C. Wainwright handhaaft koopadvies voor Biohaven met koersdoel van $ 54May 30, 2025 | nl.investing.comAandeel Biohaven raakt 52-weeks dieptepunt van $ 14,36 door marktuitdagingenMay 30, 2025 | nl.investing.comBiohaven (NYSE:BHVN) Reaches New 1-Year Low - Time to Sell?May 30, 2025 | marketbeat.comCowen handhaaft koopadvies voor Biohaven met koersdoel van $ 75May 30, 2025 | nl.investing.comBiohaven boekt vooruitgang met BHV-1400 voor behandeling IgA-nefropathieMay 30, 2025 | nl.investing.comBiohaven says anti-cancer agent cut tumor size with Regeneron’s Libtayo in Phase 1 trialMay 30, 2025 | msn.comBiohaven (NYSE:BHVN) Shares Down 3.8% - What's Next?May 29, 2025 | marketbeat.comBiohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 InhibitorMay 29, 2025 | prnewswire.comBiohaven Ltd.: Promising Pipeline and Undervaluation Justify Buy RatingMay 29, 2025 | tipranks.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 39,953 Shares of Biohaven Ltd. (NYSE:BHVN)May 29, 2025 | marketbeat.comVoloridge Investment Management LLC Trims Position in Biohaven Ltd. (NYSE:BHVN)May 29, 2025 | marketbeat.comBiohaven Ltd. (BHVN)’s BHV-1400 Cuts Disease Antibody by 81% in IgA NephropathyMay 28, 2025 | insidermonkey.comBiohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)May 28, 2025 | prnewswire.comBiohaven boekt veelbelovende resultaten met kankermedicijn BHV-1510May 28, 2025 | nl.investing.comBiohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of TumorsMay 28, 2025 | prnewswire.comInfinitum Asset Management LLC Invests $4.11 Million in Biohaven Ltd. (NYSE:BHVN)May 28, 2025 | marketbeat.comTwo Sigma Advisers LP Cuts Stock Holdings in Biohaven Ltd. (NYSE:BHVN)May 28, 2025 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Receives Average Rating of "Buy" from AnalystsMay 27, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. ...May 26, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNMay 26, 2025 | prnewswire.com Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address BHVN Media Mentions By Week BHVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼0.000.90▲Average Medical News Sentiment BHVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼18▲BHVN Articles Average Week Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Lantheus News Nuvalent News Telix Pharmaceuticals News Axsome Therapeutics News ADMA Biologics News Akero Therapeutics News Vaxcyte News Rhythm Pharmaceuticals News Krystal Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredSomething very strange is happening...What a "Mar-a-Lago Accord" could mean for the U.S. dollar While protests dominate the news... hardly anyone...Stansberry Research | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
